Cargando…
Fibroblast Growth Factor-23 (FGF-23) in Dogs—Reference Interval and Correlation with Hematological and Biochemical Parameters
SIMPLE SUMMARY: Fibroblast growth factor-23 (FGF-23) is a biomarker for the monitoring of chronic kidney disease in humans. The clinical relevance of FGF-23 in dogs is largely unknown. The aim of this study was (1) to show the intra- and interassay precision of the Kainos ELISA FGF-23 kit, (2) to de...
Autores principales: | Lapsina, Sandra, Nagler, Nicole, Müller, Simon Franz, Holtdirk, Annette, Kottmann, Tanja, Müller, Elisabeth, Schäfer, Ingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603748/ https://www.ncbi.nlm.nih.gov/pubmed/37893926 http://dx.doi.org/10.3390/ani13203202 |
Ejemplares similares
-
Comparison of Three Different Diagnostic Assays for Fibroblast Growth Factor-23 (FGF-23) Measurements in Cats: A Pilot Study
por: Lapsina, Sandra, et al.
Publicado: (2023) -
Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021) -
Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
por: Feger, Martina, et al.
Publicado: (2021) -
Molecular detection of Babesia spp. in dogs in Germany (2007–2020) and identification of potential risk factors for infection
por: Schäfer, Ingo, et al.
Publicado: (2023) -
Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)